Parallax Volatility Advisers, L.P. Cel Sci Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$7.64 - $12.49 $152,800 - $249,800
20,000 New
20,000 $220,000
Q2 2021

Aug 16, 2021
SELL
$8.68 - $27.49 $283,836 - $898,923
-32,700 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$12.0 - $27.64 $392,400 - $903,828
32,700 New
32,700 $497,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email